- Home
- DNLI vs LMAT Comparison
DNLI vs LMAT Comparison
Compare DNLI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- LMAT
- Stock Information
- Founded
- DNLI 2013
- LMAT 1983
- Country
- DNLI United States
- LMAT United States
- Employees
- DNLI N/A
- LMAT N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- LMAT Medical/Dental Instruments
- Sector
- DNLI Health Care
- LMAT Health Care
- Exchange
- DNLI Nasdaq
- LMAT Nasdaq
- Market Cap
- DNLI 2.3B
- LMAT 2.0B
- IPO Year
- DNLI 2017
- LMAT 2006
- Fundamental
- Price
- DNLI $15.21
- LMAT $87.38
- Analyst Decision
- DNLI Strong Buy
- LMAT Buy
- Analyst Count
- DNLI 15
- LMAT 6
- Target Price
- DNLI $33.50
- LMAT $99.67
- AVG Volume (30 Days)
- DNLI 2.0M
- LMAT 166.8K
- Earning Date
- DNLI 11-05-2025
- LMAT 11-06-2025
- Dividend Yield
- DNLI N/A
- LMAT 0.92%
- EPS Growth
- DNLI N/A
- LMAT 22.69
- EPS
- DNLI N/A
- LMAT 2.05
- Revenue
- DNLI N/A
- LMAT $234,639,000.00
- Revenue This Year
- DNLI N/A
- LMAT $16.27
- Revenue Next Year
- DNLI $95,463.19
- LMAT $8.29
- P/E Ratio
- DNLI N/A
- LMAT $42.60
- Revenue Growth
- DNLI N/A
- LMAT 14.11
- 52 Week Low
- DNLI $10.57
- LMAT $71.42
- 52 Week High
- DNLI $33.33
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- DNLI 54.76
- LMAT 45.70
- Support Level
- DNLI $15.03
- LMAT $86.53
- Resistance Level
- DNLI $16.51
- LMAT $88.54
- Average True Range (ATR)
- DNLI 0.80
- LMAT 2.28
- MACD
- DNLI 0.11
- LMAT 0.03
- Stochastic Oscillator
- DNLI 61.42
- LMAT 62.50
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.